Literature DB >> 2766721

Risk factors for breast fibroadenoma in young women.

R Sitruk-Ware1, J C Thalabard, A Benotmane, P Mauvais-Jarvis.   

Abstract

In a case-control study, 178 women diagnosed with fibroadenoma (FA) between 1976 and 1982 were compared with 178 age-matched controls in order to assess the risk factors for FA. Women who had a previous diagnosis of breast disease were excluded. The odds ratios (OR) of FA were calculated for different risk factors of breast disease from bivariate analysis as well as multivariate regression analysis. The highest ORs were found for a previous premenstrual mastalgia before first childbirth and a familial history (FH) of breast cancer (BC). Oral contraceptive (OC) use before a first full-term pregnancy (FFTP) does not modify this risk. Also current use of standard oral contraceptives (SOC) containing 50 micrograms of ethinyl estradiol per pill appeared to be protective and the correlation with FA was negative. These findings underline: (a) the predictive value of premenstrual mastalgia for the subsequent development of breast disease; (b) only current high-dose OC use is protective.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2766721     DOI: 10.1016/0010-7824(89)90091-7

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  3 in total

1.  Fruit and vegetable intakes are associated with lower risk of breast fibroadenomas in Chinese women.

Authors:  Zakia Coriaty Nelson; Roberta M Ray; Chunyuan Wu; Helge Stalsberg; Peggy Porter; Johanna W Lampe; Jackilen Shannon; Neilann Horner; Wenjin Li; Wenwan Wang; Yongwei Hu; Daoli Gao; David B Thomas
Journal:  J Nutr       Date:  2010-05-19       Impact factor: 4.798

2.  Juvenile fibroadenoma of the breast: Treatment and literature review.

Authors:  Wendy K Ng; M Amir Mrad; Mitchell H Brown
Journal:  Can J Plast Surg       Date:  2011

Review 3.  Breast fibroadenomas in adolescents: current perspectives.

Authors:  Michelle Lee; Hooman T Soltanian
Journal:  Adolesc Health Med Ther       Date:  2015-09-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.